Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma.

× No keyword cloud information.

17 in total

1. Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

Authors: Fidel-David Huitzil-Melendez; Marinela Capanu; Eileen M O'Reilly; Austin Duffy; Bolorsukh Gansukh; Leonard L Saltz; Ghassan K Abou-Alfa
Journal: J Clin Oncol Date: 2010-05-10 Impact factor: 44.544

2. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.

Authors: George D Demetri; Allan T van Oosterom; Christopher R Garrett; Martin E Blackstein; Manisha H Shah; Jaap Verweij; Grant McArthur; Ian R Judson; Michael C Heinrich; Jeffrey A Morgan; Jayesh Desai; Christopher D Fletcher; Suzanne George; Carlo L Bello; Xin Huang; Charles M Baum; Paolo G Casali
Journal: Lancet Date: 2006-10-14 Impact factor: 79.321

3. A cross-over response to sequential use of sunitinib after sorafenib in a patient with metastatic renal cell carcinoma.

Authors: T M Richards; P N Plowman; R Reznek; S A Ball
Journal: Clin Oncol (R Coll Radiol) Date: 2009-04-19 Impact factor: 4.126

Review 4. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

Authors: Hashem B El-Serag; K Lenhard Rudolph
Journal: Gastroenterology Date: 2007-06 Impact factor: 22.682

5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

Authors: Ann-Lii Cheng; Yoon-Koo Kang; Zhendong Chen; Chao-Jung Tsao; Shukui Qin; Jun Suk Kim; Rongcheng Luo; Jifeng Feng; Shenglong Ye; Tsai-Sheng Yang; Jianming Xu; Yan Sun; Houjie Liang; Jiwei Liu; Jiejun Wang; Won Young Tak; Hongming Pan; Karin Burock; Jessie Zou; Dimitris Voliotis; Zhongzhen Guan
Journal: Lancet Oncol Date: 2008-12-16 Impact factor: 41.316

6. Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib.

Authors: Kaja Zimmermann; Alexander Schmittel; Ursula Steiner; Anne Marie Asemissen; Maren Knoedler; Eckhard Thiel; Kurt Miller; Ulrich Keilholz
Journal: Oncology Date: 2009-03-24 Impact factor: 2.935

Review 7. Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma.

Authors: Jon J Hiles; Jill M Kolesar
Journal: Am J Health Syst Pharm Date: 2008-01-15 Impact factor: 2.637

8. Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study.

Authors: Sandrine Faivre; Eric Raymond; Eveline Boucher; Jean Douillard; Ho Y Lim; Jun S Kim; Magaly Zappa; Silvana Lanzalone; Xun Lin; Samuel Deprimo; Charles Harmon; Ana Ruiz-Garcia; Maria J Lechuga; Ann Lii Cheng
Journal: Lancet Oncol Date: 2009-07-06 Impact factor: 41.316

Review 9. Novel advancements in the management of hepatocellular carcinoma in 2008.

Authors: Josep M Llovet; Jordi Bruix
Journal: J Hepatol Date: 2008-02-12 Impact factor: 25.083

10. Sorafenib in advanced hepatocellular carcinoma.

Authors: Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal: N Engl J Med Date: 2008-07-24 Impact factor: 91.245